Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Pavan Vaddady

9PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsStochastic analysis and modellingModelling and simulationMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Apr 11, 2025
Exposure-Response Relationships in Patients with Non-Small-Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3-DXd).

Li Li, Mark Lee, Rujuta Joshi

|Nov 27, 2024
Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia.

Pavan Vaddady, Anaïs Glatard, Giovanni Smania

|Nov 13, 2024
Concentration-QTcF analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia.

Pavan Vaddady, Giovanni Smania, Shintaro Nakayama

|Oct 28, 2024
Within-chain parallelization-Giving Stan Jet Fuel for population modeling in pharmacometrics.

Casey Davis, Pavan Vaddady

|May 16, 2024
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper.

Divya Samineni, Karthik Venkatakrishnan, Ahmed A Othman

|Nov 02, 2023
Application of the model-informed drug development paradigm to datopotamab deruxtecan dose selection for late-stage development.

Yasong Lu, Shuang Liang, Ying Hong

Pageof 2

Frequent Collaborators

2 joint publications

Abhinav Kurumaddali

1 joint publications

Moises Hernandez

1 joint publications

Marcus Hompesch

1 joint publications

Linda Morrow

1 joint publications

S Aubrey Stoch

1 joint publications

Nadia Terranova

1 joint publications

Didier Renard

1 joint publications

Kumpal Madrasi

1 joint publications

Thomas Tensfeldt

1 joint publications

Nicholas Ellinwood

Frequent Collaborators

2 joint publications

Abhinav Kurumaddali

1 joint publications

Moises Hernandez

1 joint publications

Marcus Hompesch

1 joint publications

Linda Morrow

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
06:41

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Published on : Jul 19, 2024

734
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.1K
See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining
06:41

Identification of Quiescent Cells in a Zebrafish T-Cell Acute Lymphoblastic Leukemia Model Using Cell Proliferation Staining

Published on : Jul 19, 2024

734
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.1K
See more related videos